A case report documents one of only 27 known liveborn infants with complete trisomy 22, a lethal aneuploidy with a median ...

I was told the amniocentesis results came in two days earlier than expected. I received a phone call, so I headed to the ...

A new case report describes how chromosomal microarray and trio whole-exome sequencing revealed a 10.42 Mb homozygous segment ...

Recurring services and consumables, centralized high-throughput labs, automation, payer connectivity and outsourced testing support scale, efficiency and sustainable returns.Dublin, Oct. 16, 2026 ...

It’s natural after a miscarriage to ask, “Why did this happen?” While genetic testing is more commonly discussed after ...

The age at which women have their first child is rising year by year, a trend common to developed countries around the world.

Transcriptomics is the study of the transcriptome—the complete set of RNA transcripts that are produced by the genome, under specific circumstances or in a specific cell—using high-throughput methods, ...

Doctors initially told the boy's parents not to worry. But they pressed for years until a rare diagnosis became clear.

Figure 1. The 18A queue by month of latest Application Proof, coloured by the modality of each applicant's lead asset. Solid ...

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will introduce Easy Order at the 2026 American Academy of Pediatrics (AAP) ...

Pacific Biosciences of California's business model struggles to gain traction versus larger, profitable competitors like Illumina. Read why PACB stock is a buy.

Unlock ROI with segment and regional insights, competitive intelligence, growth opportunities, innovation trends, and actionable strategies for new revenue streams.Dublin, Oct. 05, 2026 (GLOBE ...